Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Evoke Pharma (EVOK) in Focus: Stock Moves 19.4% Higher
Evoke Pharma, Inc. (EVOK - Free Report) was a big mover last session, as its shares rose over 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.26 to $7.18 in the past one-month time frame.
Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Evoke Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
EVOKE PHARMA Price
EVOKE PHARMA Price | EVOKE PHARMA Quote
A better-ranked stock in the med-drugs space is Amphastar Pharmaceuticals, Inc. (AMPH - Free Report) , with a Zacks Rank #2(Buy).
Is EVOK going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>